TRACE: Selexipag ACT-293987, AC-065A404 A multicenter double-blind placebo controlled Phase 4 study in patients with pulmonary arterial hypertension to assess the effect of selexipag
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Actelion Pharmaceutical US, Inc
Start Date
January 24, 2018
End Date
June 29, 2023
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Actelion Pharmaceutical US, Inc
Start Date
January 24, 2018
End Date
June 29, 2023